On Invalid Date, Augmedix (NASDAQ: AUGX) reported Q3 2022 earnings per share (EPS) of -$0.15, up 50% year over year. Total Augmedix earnings for the quarter were -$5.49 million. In the same quarter last year, Augmedix's earnings per share (EPS) was -$0.10.
On Invalid Date, Augmedix (NASDAQ: AUGX) reported Q3 2022 revenue of $7.86 million up 39.8% year over year. In the same quarter last year, Augmedix's revenue was $5.63 million.
What was AUGX's revenue growth in the past year?
As of Q1 2023, Augmedix's revenue has grown 42.86% year over year. This is 21.61 percentage points higher than the US Health Information Services industry revenue growth rate of 21.25%. Augmedix's revenue in the past year totalled $28.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.